The 188Re-IDA-D-[c(RGDfK)]2-treated tumor tissues showed a decrease in microvessel density of approximately 60% as assessed by CD31 immunostaining (Figure 3D) and a significant decrease in positive integrin αvβ3 staining. This evidence concerns the gene PECAM1 and neoplasm.